<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 57-year-old female, who had a 14-year history of <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, developed <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Treatment with anti-lymphocyte globulin (ALG) and <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> pulse therapy achieved complete remission </plain></SENT>
<SENT sid="2" pm="."><plain>However, twenty months after ALG treatment she developed <z:hpo ids='HP_0004845'>acute monocytic leukemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In spite of the chemotherapy, consisting of <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> and <z:chebi fb="0" ids="4911">etoposide</z:chebi>, she died of <z:hpo ids='HP_0002090'>pneumonia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Recently, reports from Western countries have claimed that patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> frequently develop clonal disorders following ALG treatment </plain></SENT>
<SENT sid="5" pm="."><plain>To our knowledge, this is the first report in Japan of a case developing <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> following ALG treatment </plain></SENT>
</text></document>